RxDoctor Payments Data

Steven Smith, MD

MOHS-Micrographic Surgery · Wellesley, MANPI 1386604742

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Johnson & Johnson at 28.2% of the total. 2025 is the largest year on record at $337, more than ten times the $20 reported in 2019.

$1,208in general payments, 2019–2025

Across 53 payments — averaging $22.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$341
  • Lilly USA, LLC$298
  • Incyte Corporation$100
  • Arcutis Biotherapeutics, Inc.$82
  • Regeneron Healthcare Solutions, Inc.$61
  • Sun Pharmaceutical Industries Inc.$56
  • plus $270 from 10 others

What the payments were for

  • Food & beverage$1,208100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,208 in reported general payments places this provider in the 55th percentile of 38 mohs-micrographic surgery providers in Massachusetts.

See all mohs-micrographic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$689,671
Medicare patients
385
Services billed
1,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin59$51
Amoxicillin11$7

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Wellesley

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →